Pharma & Healthcare
Global Anticoagulant Reversal Agent Market Research Report 2026
- Feb 24, 26
- ID: 718186
- Pages: 119
- Figures: 117
- Views: 3
This report delivers a comprehensive overview of the global Anticoagulant Reversal Agent market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anticoagulant Reversal Agent. The Anticoagulant Reversal Agent market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anticoagulant Reversal Agent market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anticoagulant Reversal Agent manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
DSM
AdvaCare
Innopharma
Suicheng Pharmaceutical
Cheng Yi Pharmaceutical
Wuhu Kangqi Pharmaceuticals
Jiangsu Huayang Pharmaceutical
Brilliant Pharmaceutical
Shandong Guangtongbao Pharmaceuticals
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics
eXithera Pharmaceuticals
Ionis Pharmaceuticals
Segment by Type
Injection Fluid
Tablet
Others
Segment by Application
Hospital
Research Institute
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Anticoagulant Reversal Agent companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Anticoagulant Reversal Agent market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anticoagulant Reversal Agent manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
DSM
AdvaCare
Innopharma
Suicheng Pharmaceutical
Cheng Yi Pharmaceutical
Wuhu Kangqi Pharmaceuticals
Jiangsu Huayang Pharmaceutical
Brilliant Pharmaceutical
Shandong Guangtongbao Pharmaceuticals
Bayer AG
Bristol-Myers Squibb Company
Cambryn Biologics
eXithera Pharmaceuticals
Ionis Pharmaceuticals
Segment by Type
Injection Fluid
Tablet
Others
Segment by Application
Hospital
Research Institute
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Anticoagulant Reversal Agent companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticoagulant Reversal Agent Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Injection Fluid
1.2.3 Tablet
1.2.4 Others
1.3 Market by Application
1.3.1 Global Anticoagulant Reversal Agent Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulant Reversal Agent Market Perspective (2021–2032)
2.2 Global Anticoagulant Reversal Agent Growth Trends by Region
2.2.1 Global Anticoagulant Reversal Agent Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Anticoagulant Reversal Agent Historic Market Size by Region (2021–2026)
2.2.3 Anticoagulant Reversal Agent Forecasted Market Size by Region (2027–2032)
2.3 Anticoagulant Reversal Agent Market Dynamics
2.3.1 Anticoagulant Reversal Agent Industry Trends
2.3.2 Anticoagulant Reversal Agent Market Drivers
2.3.3 Anticoagulant Reversal Agent Market Challenges
2.3.4 Anticoagulant Reversal Agent Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anticoagulant Reversal Agent Players by Revenue
3.1.1 Global Top Anticoagulant Reversal Agent Players by Revenue (2021–2026)
3.1.2 Global Anticoagulant Reversal Agent Revenue Market Share by Players (2021–2026)
3.2 Global Top Anticoagulant Reversal Agent Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Anticoagulant Reversal Agent Revenue
3.4 Global Anticoagulant Reversal Agent Market Concentration Ratio
3.4.1 Global Anticoagulant Reversal Agent Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticoagulant Reversal Agent Revenue in 2025
3.5 Global Key Players of Anticoagulant Reversal Agent Head Offices and Areas Served
3.6 Global Key Players of Anticoagulant Reversal Agent, Products and Applications
3.7 Global Key Players of Anticoagulant Reversal Agent, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Anticoagulant Reversal Agent Breakdown Data by Type
4.1 Global Anticoagulant Reversal Agent Historic Market Size by Type (2021–2026)
4.2 Global Anticoagulant Reversal Agent Forecasted Market Size by Type (2027–2032)
5 Anticoagulant Reversal Agent Breakdown Data by Application
5.1 Global Anticoagulant Reversal Agent Historic Market Size by Application (2021–2026)
5.2 Global Anticoagulant Reversal Agent Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Anticoagulant Reversal Agent Market Size (2021–2032)
6.2 North America Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Anticoagulant Reversal Agent Market Size by Country (2021–2026)
6.4 North America Anticoagulant Reversal Agent Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anticoagulant Reversal Agent Market Size (2021–2032)
7.2 Europe Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Anticoagulant Reversal Agent Market Size by Country (2021–2026)
7.4 Europe Anticoagulant Reversal Agent Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulant Reversal Agent Market Size (2021–2032)
8.2 Asia-Pacific Anticoagulant Reversal Agent Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (2021–2026)
8.4 Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Anticoagulant Reversal Agent Market Size (2021–2032)
9.2 Latin America Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Anticoagulant Reversal Agent Market Size by Country (2021–2026)
9.4 Latin America Anticoagulant Reversal Agent Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulant Reversal Agent Market Size (2021–2032)
10.2 Middle East & Africa Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2021–2026)
10.4 Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DSM
11.1.1 DSM Company Details
11.1.2 DSM Business Overview
11.1.3 DSM Anticoagulant Reversal Agent Introduction
11.1.4 DSM Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.1.5 DSM Recent Development
11.2 AdvaCare
11.2.1 AdvaCare Company Details
11.2.2 AdvaCare Business Overview
11.2.3 AdvaCare Anticoagulant Reversal Agent Introduction
11.2.4 AdvaCare Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.2.5 AdvaCare Recent Development
11.3 Innopharma
11.3.1 Innopharma Company Details
11.3.2 Innopharma Business Overview
11.3.3 Innopharma Anticoagulant Reversal Agent Introduction
11.3.4 Innopharma Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.3.5 Innopharma Recent Development
11.4 Suicheng Pharmaceutical
11.4.1 Suicheng Pharmaceutical Company Details
11.4.2 Suicheng Pharmaceutical Business Overview
11.4.3 Suicheng Pharmaceutical Anticoagulant Reversal Agent Introduction
11.4.4 Suicheng Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.4.5 Suicheng Pharmaceutical Recent Development
11.5 Cheng Yi Pharmaceutical
11.5.1 Cheng Yi Pharmaceutical Company Details
11.5.2 Cheng Yi Pharmaceutical Business Overview
11.5.3 Cheng Yi Pharmaceutical Anticoagulant Reversal Agent Introduction
11.5.4 Cheng Yi Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.5.5 Cheng Yi Pharmaceutical Recent Development
11.6 Wuhu Kangqi Pharmaceuticals
11.6.1 Wuhu Kangqi Pharmaceuticals Company Details
11.6.2 Wuhu Kangqi Pharmaceuticals Business Overview
11.6.3 Wuhu Kangqi Pharmaceuticals Anticoagulant Reversal Agent Introduction
11.6.4 Wuhu Kangqi Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.6.5 Wuhu Kangqi Pharmaceuticals Recent Development
11.7 Jiangsu Huayang Pharmaceutical
11.7.1 Jiangsu Huayang Pharmaceutical Company Details
11.7.2 Jiangsu Huayang Pharmaceutical Business Overview
11.7.3 Jiangsu Huayang Pharmaceutical Anticoagulant Reversal Agent Introduction
11.7.4 Jiangsu Huayang Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.7.5 Jiangsu Huayang Pharmaceutical Recent Development
11.8 Brilliant Pharmaceutical
11.8.1 Brilliant Pharmaceutical Company Details
11.8.2 Brilliant Pharmaceutical Business Overview
11.8.3 Brilliant Pharmaceutical Anticoagulant Reversal Agent Introduction
11.8.4 Brilliant Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.8.5 Brilliant Pharmaceutical Recent Development
11.9 Shandong Guangtongbao Pharmaceuticals
11.9.1 Shandong Guangtongbao Pharmaceuticals Company Details
11.9.2 Shandong Guangtongbao Pharmaceuticals Business Overview
11.9.3 Shandong Guangtongbao Pharmaceuticals Anticoagulant Reversal Agent Introduction
11.9.4 Shandong Guangtongbao Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.9.5 Shandong Guangtongbao Pharmaceuticals Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Anticoagulant Reversal Agent Introduction
11.10.4 Bayer AG Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.10.5 Bayer AG Recent Development
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Details
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Anticoagulant Reversal Agent Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.11.5 Bristol-Myers Squibb Company Recent Development
11.12 Cambryn Biologics
11.12.1 Cambryn Biologics Company Details
11.12.2 Cambryn Biologics Business Overview
11.12.3 Cambryn Biologics Anticoagulant Reversal Agent Introduction
11.12.4 Cambryn Biologics Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.12.5 Cambryn Biologics Recent Development
11.13 eXithera Pharmaceuticals
11.13.1 eXithera Pharmaceuticals Company Details
11.13.2 eXithera Pharmaceuticals Business Overview
11.13.3 eXithera Pharmaceuticals Anticoagulant Reversal Agent Introduction
11.13.4 eXithera Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.13.5 eXithera Pharmaceuticals Recent Development
11.14 Ionis Pharmaceuticals
11.14.1 Ionis Pharmaceuticals Company Details
11.14.2 Ionis Pharmaceuticals Business Overview
11.14.3 Ionis Pharmaceuticals Anticoagulant Reversal Agent Introduction
11.14.4 Ionis Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.14.5 Ionis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticoagulant Reversal Agent Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Injection Fluid
1.2.3 Tablet
1.2.4 Others
1.3 Market by Application
1.3.1 Global Anticoagulant Reversal Agent Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulant Reversal Agent Market Perspective (2021–2032)
2.2 Global Anticoagulant Reversal Agent Growth Trends by Region
2.2.1 Global Anticoagulant Reversal Agent Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Anticoagulant Reversal Agent Historic Market Size by Region (2021–2026)
2.2.3 Anticoagulant Reversal Agent Forecasted Market Size by Region (2027–2032)
2.3 Anticoagulant Reversal Agent Market Dynamics
2.3.1 Anticoagulant Reversal Agent Industry Trends
2.3.2 Anticoagulant Reversal Agent Market Drivers
2.3.3 Anticoagulant Reversal Agent Market Challenges
2.3.4 Anticoagulant Reversal Agent Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anticoagulant Reversal Agent Players by Revenue
3.1.1 Global Top Anticoagulant Reversal Agent Players by Revenue (2021–2026)
3.1.2 Global Anticoagulant Reversal Agent Revenue Market Share by Players (2021–2026)
3.2 Global Top Anticoagulant Reversal Agent Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Anticoagulant Reversal Agent Revenue
3.4 Global Anticoagulant Reversal Agent Market Concentration Ratio
3.4.1 Global Anticoagulant Reversal Agent Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticoagulant Reversal Agent Revenue in 2025
3.5 Global Key Players of Anticoagulant Reversal Agent Head Offices and Areas Served
3.6 Global Key Players of Anticoagulant Reversal Agent, Products and Applications
3.7 Global Key Players of Anticoagulant Reversal Agent, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Anticoagulant Reversal Agent Breakdown Data by Type
4.1 Global Anticoagulant Reversal Agent Historic Market Size by Type (2021–2026)
4.2 Global Anticoagulant Reversal Agent Forecasted Market Size by Type (2027–2032)
5 Anticoagulant Reversal Agent Breakdown Data by Application
5.1 Global Anticoagulant Reversal Agent Historic Market Size by Application (2021–2026)
5.2 Global Anticoagulant Reversal Agent Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Anticoagulant Reversal Agent Market Size (2021–2032)
6.2 North America Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Anticoagulant Reversal Agent Market Size by Country (2021–2026)
6.4 North America Anticoagulant Reversal Agent Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anticoagulant Reversal Agent Market Size (2021–2032)
7.2 Europe Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Anticoagulant Reversal Agent Market Size by Country (2021–2026)
7.4 Europe Anticoagulant Reversal Agent Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulant Reversal Agent Market Size (2021–2032)
8.2 Asia-Pacific Anticoagulant Reversal Agent Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (2021–2026)
8.4 Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Anticoagulant Reversal Agent Market Size (2021–2032)
9.2 Latin America Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Anticoagulant Reversal Agent Market Size by Country (2021–2026)
9.4 Latin America Anticoagulant Reversal Agent Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulant Reversal Agent Market Size (2021–2032)
10.2 Middle East & Africa Anticoagulant Reversal Agent Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2021–2026)
10.4 Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DSM
11.1.1 DSM Company Details
11.1.2 DSM Business Overview
11.1.3 DSM Anticoagulant Reversal Agent Introduction
11.1.4 DSM Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.1.5 DSM Recent Development
11.2 AdvaCare
11.2.1 AdvaCare Company Details
11.2.2 AdvaCare Business Overview
11.2.3 AdvaCare Anticoagulant Reversal Agent Introduction
11.2.4 AdvaCare Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.2.5 AdvaCare Recent Development
11.3 Innopharma
11.3.1 Innopharma Company Details
11.3.2 Innopharma Business Overview
11.3.3 Innopharma Anticoagulant Reversal Agent Introduction
11.3.4 Innopharma Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.3.5 Innopharma Recent Development
11.4 Suicheng Pharmaceutical
11.4.1 Suicheng Pharmaceutical Company Details
11.4.2 Suicheng Pharmaceutical Business Overview
11.4.3 Suicheng Pharmaceutical Anticoagulant Reversal Agent Introduction
11.4.4 Suicheng Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.4.5 Suicheng Pharmaceutical Recent Development
11.5 Cheng Yi Pharmaceutical
11.5.1 Cheng Yi Pharmaceutical Company Details
11.5.2 Cheng Yi Pharmaceutical Business Overview
11.5.3 Cheng Yi Pharmaceutical Anticoagulant Reversal Agent Introduction
11.5.4 Cheng Yi Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.5.5 Cheng Yi Pharmaceutical Recent Development
11.6 Wuhu Kangqi Pharmaceuticals
11.6.1 Wuhu Kangqi Pharmaceuticals Company Details
11.6.2 Wuhu Kangqi Pharmaceuticals Business Overview
11.6.3 Wuhu Kangqi Pharmaceuticals Anticoagulant Reversal Agent Introduction
11.6.4 Wuhu Kangqi Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.6.5 Wuhu Kangqi Pharmaceuticals Recent Development
11.7 Jiangsu Huayang Pharmaceutical
11.7.1 Jiangsu Huayang Pharmaceutical Company Details
11.7.2 Jiangsu Huayang Pharmaceutical Business Overview
11.7.3 Jiangsu Huayang Pharmaceutical Anticoagulant Reversal Agent Introduction
11.7.4 Jiangsu Huayang Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.7.5 Jiangsu Huayang Pharmaceutical Recent Development
11.8 Brilliant Pharmaceutical
11.8.1 Brilliant Pharmaceutical Company Details
11.8.2 Brilliant Pharmaceutical Business Overview
11.8.3 Brilliant Pharmaceutical Anticoagulant Reversal Agent Introduction
11.8.4 Brilliant Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.8.5 Brilliant Pharmaceutical Recent Development
11.9 Shandong Guangtongbao Pharmaceuticals
11.9.1 Shandong Guangtongbao Pharmaceuticals Company Details
11.9.2 Shandong Guangtongbao Pharmaceuticals Business Overview
11.9.3 Shandong Guangtongbao Pharmaceuticals Anticoagulant Reversal Agent Introduction
11.9.4 Shandong Guangtongbao Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.9.5 Shandong Guangtongbao Pharmaceuticals Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Anticoagulant Reversal Agent Introduction
11.10.4 Bayer AG Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.10.5 Bayer AG Recent Development
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Details
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Anticoagulant Reversal Agent Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.11.5 Bristol-Myers Squibb Company Recent Development
11.12 Cambryn Biologics
11.12.1 Cambryn Biologics Company Details
11.12.2 Cambryn Biologics Business Overview
11.12.3 Cambryn Biologics Anticoagulant Reversal Agent Introduction
11.12.4 Cambryn Biologics Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.12.5 Cambryn Biologics Recent Development
11.13 eXithera Pharmaceuticals
11.13.1 eXithera Pharmaceuticals Company Details
11.13.2 eXithera Pharmaceuticals Business Overview
11.13.3 eXithera Pharmaceuticals Anticoagulant Reversal Agent Introduction
11.13.4 eXithera Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.13.5 eXithera Pharmaceuticals Recent Development
11.14 Ionis Pharmaceuticals
11.14.1 Ionis Pharmaceuticals Company Details
11.14.2 Ionis Pharmaceuticals Business Overview
11.14.3 Ionis Pharmaceuticals Anticoagulant Reversal Agent Introduction
11.14.4 Ionis Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (2021–2026)
11.14.5 Ionis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anticoagulant Reversal Agent Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Injection Fluid
Table 3. Key Players of Tablet
Table 4. Key Players of Others
Table 5. Global Anticoagulant Reversal Agent Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Anticoagulant Reversal Agent Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Anticoagulant Reversal Agent Market Size by Region (US$ Million), 2021–2026
Table 8. Global Anticoagulant Reversal Agent Market Share by Region (2021–2026)
Table 9. Global Anticoagulant Reversal Agent Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Anticoagulant Reversal Agent Market Share by Region (2027–2032)
Table 11. Anticoagulant Reversal Agent Market Trends
Table 12. Anticoagulant Reversal Agent Market Drivers
Table 13. Anticoagulant Reversal Agent Market Challenges
Table 14. Anticoagulant Reversal Agent Market Restraints
Table 15. Global Anticoagulant Reversal Agent Revenue by Players (US$ Million), 2021–2026
Table 16. Global Anticoagulant Reversal Agent Market Share by Players (2021–2026)
Table 17. Global Top Anticoagulant Reversal Agent Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anticoagulant Reversal Agent Revenue, 2025
Table 18. Ranking of Global Top Anticoagulant Reversal Agent Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Anticoagulant Reversal Agent Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Anticoagulant Reversal Agent, Headquarters and Area Served
Table 21. Global Key Players of Anticoagulant Reversal Agent, Products and Applications
Table 22. Global Key Players of Anticoagulant Reversal Agent, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Anticoagulant Reversal Agent Market Size by Type (US$ Million), 2021–2026
Table 25. Global Anticoagulant Reversal Agent Revenue Market Share by Type (2021–2026)
Table 26. Global Anticoagulant Reversal Agent Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Anticoagulant Reversal Agent Revenue Market Share by Type (2027–2032)
Table 28. Global Anticoagulant Reversal Agent Market Size by Application (US$ Million), 2021–2026
Table 29. Global Anticoagulant Reversal Agent Revenue Market Share by Application (2021–2026)
Table 30. Global Anticoagulant Reversal Agent Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Anticoagulant Reversal Agent Revenue Market Share by Application (2027–2032)
Table 32. North America Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026
Table 34. North America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Anticoagulant Reversal Agent Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032
Table 47. DSM Company Details
Table 48. DSM Business Overview
Table 49. DSM Anticoagulant Reversal Agent Product
Table 50. DSM Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 51. DSM Recent Development
Table 52. AdvaCare Company Details
Table 53. AdvaCare Business Overview
Table 54. AdvaCare Anticoagulant Reversal Agent Product
Table 55. AdvaCare Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 56. AdvaCare Recent Development
Table 57. Innopharma Company Details
Table 58. Innopharma Business Overview
Table 59. Innopharma Anticoagulant Reversal Agent Product
Table 60. Innopharma Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 61. Innopharma Recent Development
Table 62. Suicheng Pharmaceutical Company Details
Table 63. Suicheng Pharmaceutical Business Overview
Table 64. Suicheng Pharmaceutical Anticoagulant Reversal Agent Product
Table 65. Suicheng Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 66. Suicheng Pharmaceutical Recent Development
Table 67. Cheng Yi Pharmaceutical Company Details
Table 68. Cheng Yi Pharmaceutical Business Overview
Table 69. Cheng Yi Pharmaceutical Anticoagulant Reversal Agent Product
Table 70. Cheng Yi Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 71. Cheng Yi Pharmaceutical Recent Development
Table 72. Wuhu Kangqi Pharmaceuticals Company Details
Table 73. Wuhu Kangqi Pharmaceuticals Business Overview
Table 74. Wuhu Kangqi Pharmaceuticals Anticoagulant Reversal Agent Product
Table 75. Wuhu Kangqi Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 76. Wuhu Kangqi Pharmaceuticals Recent Development
Table 77. Jiangsu Huayang Pharmaceutical Company Details
Table 78. Jiangsu Huayang Pharmaceutical Business Overview
Table 79. Jiangsu Huayang Pharmaceutical Anticoagulant Reversal Agent Product
Table 80. Jiangsu Huayang Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 81. Jiangsu Huayang Pharmaceutical Recent Development
Table 82. Brilliant Pharmaceutical Company Details
Table 83. Brilliant Pharmaceutical Business Overview
Table 84. Brilliant Pharmaceutical Anticoagulant Reversal Agent Product
Table 85. Brilliant Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 86. Brilliant Pharmaceutical Recent Development
Table 87. Shandong Guangtongbao Pharmaceuticals Company Details
Table 88. Shandong Guangtongbao Pharmaceuticals Business Overview
Table 89. Shandong Guangtongbao Pharmaceuticals Anticoagulant Reversal Agent Product
Table 90. Shandong Guangtongbao Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 91. Shandong Guangtongbao Pharmaceuticals Recent Development
Table 92. Bayer AG Company Details
Table 93. Bayer AG Business Overview
Table 94. Bayer AG Anticoagulant Reversal Agent Product
Table 95. Bayer AG Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 96. Bayer AG Recent Development
Table 97. Bristol-Myers Squibb Company Company Details
Table 98. Bristol-Myers Squibb Company Business Overview
Table 99. Bristol-Myers Squibb Company Anticoagulant Reversal Agent Product
Table 100. Bristol-Myers Squibb Company Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 101. Bristol-Myers Squibb Company Recent Development
Table 102. Cambryn Biologics Company Details
Table 103. Cambryn Biologics Business Overview
Table 104. Cambryn Biologics Anticoagulant Reversal Agent Product
Table 105. Cambryn Biologics Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 106. Cambryn Biologics Recent Development
Table 107. eXithera Pharmaceuticals Company Details
Table 108. eXithera Pharmaceuticals Business Overview
Table 109. eXithera Pharmaceuticals Anticoagulant Reversal Agent Product
Table 110. eXithera Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 111. eXithera Pharmaceuticals Recent Development
Table 112. Ionis Pharmaceuticals Company Details
Table 113. Ionis Pharmaceuticals Business Overview
Table 114. Ionis Pharmaceuticals Anticoagulant Reversal Agent Product
Table 115. Ionis Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 116. Ionis Pharmaceuticals Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Anticoagulant Reversal Agent Picture
Figure 2. Global Anticoagulant Reversal Agent Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Anticoagulant Reversal Agent Market Share by Type: 2025 vs 2032
Figure 4. Injection Fluid Features
Figure 5. Tablet Features
Figure 6. Others Features
Figure 7. Global Anticoagulant Reversal Agent Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Anticoagulant Reversal Agent Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Others Case Studies
Figure 12. Anticoagulant Reversal Agent Report Years Considered
Figure 13. Global Anticoagulant Reversal Agent Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Anticoagulant Reversal Agent Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Anticoagulant Reversal Agent Market Share by Region: 2025 vs 2032
Figure 16. Global Anticoagulant Reversal Agent Market Share by Players in 2025
Figure 17. Global Anticoagulant Reversal Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Anticoagulant Reversal Agent Revenue in 2025
Figure 19. North America Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Anticoagulant Reversal Agent Market Share by Country (2021–2032)
Figure 21. United States Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Anticoagulant Reversal Agent Market Share by Country (2021–2032)
Figure 25. Germany Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Anticoagulant Reversal Agent Market Share by Region (2021–2032)
Figure 33. China Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Anticoagulant Reversal Agent Market Share by Country (2021–2032)
Figure 41. Mexico Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Anticoagulant Reversal Agent Market Share by Country (2021–2032)
Figure 45. Israel Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. DSM Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 49. AdvaCare Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 50. Innopharma Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 51. Suicheng Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 52. Cheng Yi Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 53. Wuhu Kangqi Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 54. Jiangsu Huayang Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 55. Brilliant Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 56. Shandong Guangtongbao Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 57. Bayer AG Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 58. Bristol-Myers Squibb Company Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 59. Cambryn Biologics Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 60. eXithera Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 61. Ionis Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Anticoagulant Reversal Agent Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Injection Fluid
Table 3. Key Players of Tablet
Table 4. Key Players of Others
Table 5. Global Anticoagulant Reversal Agent Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Anticoagulant Reversal Agent Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Anticoagulant Reversal Agent Market Size by Region (US$ Million), 2021–2026
Table 8. Global Anticoagulant Reversal Agent Market Share by Region (2021–2026)
Table 9. Global Anticoagulant Reversal Agent Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Anticoagulant Reversal Agent Market Share by Region (2027–2032)
Table 11. Anticoagulant Reversal Agent Market Trends
Table 12. Anticoagulant Reversal Agent Market Drivers
Table 13. Anticoagulant Reversal Agent Market Challenges
Table 14. Anticoagulant Reversal Agent Market Restraints
Table 15. Global Anticoagulant Reversal Agent Revenue by Players (US$ Million), 2021–2026
Table 16. Global Anticoagulant Reversal Agent Market Share by Players (2021–2026)
Table 17. Global Top Anticoagulant Reversal Agent Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anticoagulant Reversal Agent Revenue, 2025
Table 18. Ranking of Global Top Anticoagulant Reversal Agent Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Anticoagulant Reversal Agent Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Anticoagulant Reversal Agent, Headquarters and Area Served
Table 21. Global Key Players of Anticoagulant Reversal Agent, Products and Applications
Table 22. Global Key Players of Anticoagulant Reversal Agent, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Anticoagulant Reversal Agent Market Size by Type (US$ Million), 2021–2026
Table 25. Global Anticoagulant Reversal Agent Revenue Market Share by Type (2021–2026)
Table 26. Global Anticoagulant Reversal Agent Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Anticoagulant Reversal Agent Revenue Market Share by Type (2027–2032)
Table 28. Global Anticoagulant Reversal Agent Market Size by Application (US$ Million), 2021–2026
Table 29. Global Anticoagulant Reversal Agent Revenue Market Share by Application (2021–2026)
Table 30. Global Anticoagulant Reversal Agent Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Anticoagulant Reversal Agent Revenue Market Share by Application (2027–2032)
Table 32. North America Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026
Table 34. North America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Anticoagulant Reversal Agent Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Anticoagulant Reversal Agent Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Anticoagulant Reversal Agent Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Anticoagulant Reversal Agent Market Size by Country (US$ Million), 2027–2032
Table 47. DSM Company Details
Table 48. DSM Business Overview
Table 49. DSM Anticoagulant Reversal Agent Product
Table 50. DSM Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 51. DSM Recent Development
Table 52. AdvaCare Company Details
Table 53. AdvaCare Business Overview
Table 54. AdvaCare Anticoagulant Reversal Agent Product
Table 55. AdvaCare Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 56. AdvaCare Recent Development
Table 57. Innopharma Company Details
Table 58. Innopharma Business Overview
Table 59. Innopharma Anticoagulant Reversal Agent Product
Table 60. Innopharma Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 61. Innopharma Recent Development
Table 62. Suicheng Pharmaceutical Company Details
Table 63. Suicheng Pharmaceutical Business Overview
Table 64. Suicheng Pharmaceutical Anticoagulant Reversal Agent Product
Table 65. Suicheng Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 66. Suicheng Pharmaceutical Recent Development
Table 67. Cheng Yi Pharmaceutical Company Details
Table 68. Cheng Yi Pharmaceutical Business Overview
Table 69. Cheng Yi Pharmaceutical Anticoagulant Reversal Agent Product
Table 70. Cheng Yi Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 71. Cheng Yi Pharmaceutical Recent Development
Table 72. Wuhu Kangqi Pharmaceuticals Company Details
Table 73. Wuhu Kangqi Pharmaceuticals Business Overview
Table 74. Wuhu Kangqi Pharmaceuticals Anticoagulant Reversal Agent Product
Table 75. Wuhu Kangqi Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 76. Wuhu Kangqi Pharmaceuticals Recent Development
Table 77. Jiangsu Huayang Pharmaceutical Company Details
Table 78. Jiangsu Huayang Pharmaceutical Business Overview
Table 79. Jiangsu Huayang Pharmaceutical Anticoagulant Reversal Agent Product
Table 80. Jiangsu Huayang Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 81. Jiangsu Huayang Pharmaceutical Recent Development
Table 82. Brilliant Pharmaceutical Company Details
Table 83. Brilliant Pharmaceutical Business Overview
Table 84. Brilliant Pharmaceutical Anticoagulant Reversal Agent Product
Table 85. Brilliant Pharmaceutical Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 86. Brilliant Pharmaceutical Recent Development
Table 87. Shandong Guangtongbao Pharmaceuticals Company Details
Table 88. Shandong Guangtongbao Pharmaceuticals Business Overview
Table 89. Shandong Guangtongbao Pharmaceuticals Anticoagulant Reversal Agent Product
Table 90. Shandong Guangtongbao Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 91. Shandong Guangtongbao Pharmaceuticals Recent Development
Table 92. Bayer AG Company Details
Table 93. Bayer AG Business Overview
Table 94. Bayer AG Anticoagulant Reversal Agent Product
Table 95. Bayer AG Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 96. Bayer AG Recent Development
Table 97. Bristol-Myers Squibb Company Company Details
Table 98. Bristol-Myers Squibb Company Business Overview
Table 99. Bristol-Myers Squibb Company Anticoagulant Reversal Agent Product
Table 100. Bristol-Myers Squibb Company Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 101. Bristol-Myers Squibb Company Recent Development
Table 102. Cambryn Biologics Company Details
Table 103. Cambryn Biologics Business Overview
Table 104. Cambryn Biologics Anticoagulant Reversal Agent Product
Table 105. Cambryn Biologics Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 106. Cambryn Biologics Recent Development
Table 107. eXithera Pharmaceuticals Company Details
Table 108. eXithera Pharmaceuticals Business Overview
Table 109. eXithera Pharmaceuticals Anticoagulant Reversal Agent Product
Table 110. eXithera Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 111. eXithera Pharmaceuticals Recent Development
Table 112. Ionis Pharmaceuticals Company Details
Table 113. Ionis Pharmaceuticals Business Overview
Table 114. Ionis Pharmaceuticals Anticoagulant Reversal Agent Product
Table 115. Ionis Pharmaceuticals Revenue in Anticoagulant Reversal Agent Business (US$ Million), 2021–2026
Table 116. Ionis Pharmaceuticals Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Anticoagulant Reversal Agent Picture
Figure 2. Global Anticoagulant Reversal Agent Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Anticoagulant Reversal Agent Market Share by Type: 2025 vs 2032
Figure 4. Injection Fluid Features
Figure 5. Tablet Features
Figure 6. Others Features
Figure 7. Global Anticoagulant Reversal Agent Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Anticoagulant Reversal Agent Market Share by Application: 2025 vs 2032
Figure 9. Hospital Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Others Case Studies
Figure 12. Anticoagulant Reversal Agent Report Years Considered
Figure 13. Global Anticoagulant Reversal Agent Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Anticoagulant Reversal Agent Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Anticoagulant Reversal Agent Market Share by Region: 2025 vs 2032
Figure 16. Global Anticoagulant Reversal Agent Market Share by Players in 2025
Figure 17. Global Anticoagulant Reversal Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Anticoagulant Reversal Agent Revenue in 2025
Figure 19. North America Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Anticoagulant Reversal Agent Market Share by Country (2021–2032)
Figure 21. United States Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Anticoagulant Reversal Agent Market Share by Country (2021–2032)
Figure 25. Germany Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Anticoagulant Reversal Agent Market Share by Region (2021–2032)
Figure 33. China Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Anticoagulant Reversal Agent Market Share by Country (2021–2032)
Figure 41. Mexico Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Anticoagulant Reversal Agent Market Share by Country (2021–2032)
Figure 45. Israel Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Anticoagulant Reversal Agent Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. DSM Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 49. AdvaCare Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 50. Innopharma Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 51. Suicheng Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 52. Cheng Yi Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 53. Wuhu Kangqi Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 54. Jiangsu Huayang Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 55. Brilliant Pharmaceutical Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 56. Shandong Guangtongbao Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 57. Bayer AG Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 58. Bristol-Myers Squibb Company Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 59. Cambryn Biologics Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 60. eXithera Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 61. Ionis Pharmaceuticals Revenue Growth Rate in Anticoagulant Reversal Agent Business (2021–2026)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232